Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?

Alex Carchidi, The Motley Fool
·4-min read
Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?
Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?

Over the past several months, investors have gotten a few reminders that experimental vaccines can pose risks to trial participants. In turn, unexpected side effects and delays in the clinical trial process can punish stock prices. AstraZeneca's (NYSE: AZN) coronavirus vaccine trial is still on hold in the U.S. after a clinical trial participant experienced rare, severe, and potentially permanent side effects.